Cotización EXMAR NV - EXM | ADVFN

US Dollar vs MXN

Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

Regístrate

Inicio
Invertir
Acciones
Europa
EU
EXMAR NV (EXM) Cotización

EXMAR NV (EXM)

8.30

0.00

( 0.00% )

Actualizado: 08:53:17

Delayed by 15 minutes

Su centro para precios en tiempo real, ideas y debates en vivo

Último Precio

8.30

Postura de Compra

8.26

Postura de Venta

8.35

Volume Operado de la Acción

19,754

8.10 Rango del Día 8.39

7.01 Rango de 52 semanas 10.00

Capitalización de Mercado [m]

Precio Anterior

8.30

Precio de Apertura

8.25

Hora

Última hora de negociación

08:53:16

Volumen financiero

-

Precio Promedio Ponderado

-

Volumen promedio (3 m)

17,264

Acciones en circulación

59,500,000

Rendimiento del Dividendo

-

Ratio Precio/Utilidad

6.83

Beneficio por acción (BPA)

1.21

turnover

492.21M

Beneficio neto

71.97M

Sector

Crude Petroleum Pipelines

Industria

Crude Petroleum Pipelines

Sitio web

www.exmar.com

Sede

Antwerp, Antwerp, Bel

Fundado

-

EXMAR NV is listed in the Crude Petroleum Pipelines sector of the Euronext with ticker EXM. The last closing price for EXMAR NV was 8.30 €. Over the last year, EXMAR NV shares have traded in a share price range of 7.01 € to 10.00 €.

EXMAR NV currently has 59,500,000 shares in issue. The market capitalisation of EXMAR NV is 493.85 € million. EXMAR NV has a price to earnings ratio (PE ratio) of 6.83.

Connect Online with Major LNG and LPG Company Executives

Get Expert Updates On Markets & Outlook A Pioneering Initiative - Keeping Our Sense Of Community, Information Flow & Industry Connectivity at Capital Link’s 14th Annual Digital...

Marine Money's 19th Annual Marine Money Week Investor Conference

New York City - June 21st & 22nd, 2006 STAMFORD, Conn., June 7 /PRNewswire/ -- On Wednesday, June 21st and Thursday, June 22nd, Marine Money International and JPMorgan will host the 19th annual...

Período †	Variación(Ptos)	Variación %	Apertura	Precio Máximo	Precio Mínimo	Avg. Vol. diario	Precio Promedio Ponderado
1	0.24	2.9776674938	8.06	8.47	8	6056	8.24875962	DE
4	0.56	7.23514211886	7.74	8.47	7.6	16396	7.93488733	DE
12	-0.7	-7.77777777778	9	10	7.56	17264	8.33745365	DE
26	0.78	10.3723404255	7.52	10	7.3	12267	8.16334813	DE
52	0.94	12.7717391304	7.36	10	7.01	13522	7.81864066	DE
156	4.21	102.93398533	4.09	12.08	3.815	74964	8.78432322	DE
260	2.91	53.9888682746	5.39	12.08	1.75	67374	7.11682255	DE

Volumen
% Mayores Alzas
% Mayores Bajas

Símbolo	Precio	Vol.
ALDRVDrone Volt	0.34 € (8,847.37%)	107.31k
ALNEVNeovacs	0.0003 € (50.00%)	38.68M
TRACTTeract SA	1.18 € (39.15%)	166.35k
ALSPWSpineway	0.129 € (22.04%)	4.49M
ALARFAdeunis	0.896 € (20.75%)	17.22k
ATOAtos SE	0.7226 € (-19.46%)	9.41M
ALTAILighton	14.498 € (-19.46%)	95.3k
ALEUPEuroplasma	0.077 € (-18.95%)	2.52M
ALVGVEOM Group	0.151 € (-16.11%)	12.65k
OSEOSE Immunotherapeutics	7.55 € (-14.50%)	624.45k
ALNEVNeovacs	0.0003 € (50.00%)	38.68M
ALCYBCybergun	0.0001 € (0.00%)	35.1M
BCPBanco Comercial Portugues SA	0.4421 € (-1.27%)	21.71M
LATLatecoere	0.0089 € (11.25%)	20.41M
ALHPIHopium SA	0.009 € (1.12%)	12.78M

jbsliverer

jbsliverer 1 minuto hace

Criminals keep criming, China criminals still partnering with traitor criminal trump as he keeps selling America to foreign adversaries. Nothing not expected, expect it to get a LOT worse.

https://bsky.app/profile/emptywheel.bsky.social/post/3lcd7stdgnk2o

.

02opida

02opida 2 minutos hace

21 ~ up from 17 in Central Pa this AM

gp22

gp22 2 minutos hace

Starting to pull away: : $VVOS @ $3.40s: Microfloat. Cash rich. Recent FDA Approval of only device for Sleep Apnea. Upgraded two weeks ago to $6.00+ Valuation....New Sleep Apnea patent granted last week.
Coming off lows on elevated volume last week. ..Super tight Float. Moving up...$VVOS ripe

02opida

02opida 2 minutos hace

58* EARLY MORNING

firebag1

firebag1 2 minutos hace

smack smack great buys hugely outnumbering sells!!! lets clean out these flippers!!!! this is sooooooooooooooooooooooooooooooooooooooooooooo undervalued!! good luck fella

gp22

gp22 2 minutos hace

Starting to pull away: : $VVOS @ $3.40s: Microfloat. Cash rich. Recent FDA Approval of only device for Sleep Apnea. Upgraded two weeks ago to $6.00+ Valuation....New Sleep Apnea patent granted last week.
Coming off lows on elevated volume last week. ..Super tight Float. Moving up...$VVOS ripe

Hitman970

Hitman970 2 minutos hace

No letter from Schwab

jxyzobrien

jxyzobrien 2 minutos hace

chart must match fundamentals
chart still good
one day of in store weakness is not enough
looks like 100 to come next
this market is just focused on going higher
new policies are not in cement yet and can not be determined

https://schrts.co/aKtzKAwx

81vette

81vette 2 minutos hace

Events soon and split canceled could move thru resistance,astronomical potential = huge greed ;-)

UOENO

UOENO 3 minutos hace

02opida

02opida 3 minutos hace

$HTOO / BUYOUT $QIND

toohot

toohot 3 minutos hace

From another board an additional five stars:

Keep us posted I have continually suffered back strains from my vigorous running weight training and zumba cardio workouts. The Actipatch has helped rehab my rotator cuff surgery and continues to help my partially torn and aging meniscus. I

BIEL TILLABELIE

Budots

Budots 3 minutos hace

$ZEPP announced the launch of the enhanced Zepp App 9. https://finance.yahoo.com/news/zepp-health-launches-enhanced-zepp-150000737.html

Budots

Budots 3 minutos hace

$ZEPP announced the launch of the enhanced Zepp App 9. https://finance.yahoo.com/news/zepp-health-launches-enhanced-zepp-150000737.html

Chiron

Chiron 3 minutos hace

‘The Team’ has been alerted. It’s on the ‘Raadr’

Get IN.

rbl100

rbl100 3 minutos hace

Not really LOL. But if you mean burning to the ground, then you are correct.

jmgotch

jmgotch 3 minutos hace

I have E*Trade. No letter. On my end

02opida

02opida 3 minutos hace

NEW YORK, Dec. 02, 2024 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB) a clinical-stage biopharmaceutical company developing innovative gamma-delta T cell therapies, today announced that William Ho, CEO and co-founder, will present at NobleCon20 - Noble Capital Markets' Twentieth Annual Emerging Gr

Checkmate 36

Checkmate 36 3 minutos hace

You don’t think MHRA is going to approve?
Once they do, I’m sure you are going to tuck the approval into your “cunning” allegation.

Sorry man but there are a lot of MD’s that know of and are agreeing that the tech is groundbreaking. That will trend quickly in Med field once ap

Screech691

Screech691 4 minutos hace

Unlock Soil Nutrients
This contributes to improved nutrient transfer, improved soil structure, better water holding capacity and better overall soil health. Regular use of XLR8® Bio incubates the activity responsible for water manufacture in soil.

AsianSong

AsianSong 4 minutos hace

Where in the financials do you see $5 Million in revenue? WIshing and wanting it to be so DOESNT make it so.

AyaStocks

AyaStocks 4 minutos hace

"Something's is going on behind the scenes ... OTCmarkets does not remove "shell status" for no reason ... I believe company and OTCmarkets are talking ... Something was shown ... Shell Risk was removed." I agree something's occurring behind the scenes! I'm watching this ticker closely in case we ma

Screech691

Screech691 4 minutos hace

Carbon Sequestration
XLR8® Bio also helps to enhance carbon sequestration and biological nitrogen fixation in the soil. With continued use of Organic fertilizer this activity builds humus and enhances michorrizal activity in the critical root zone.

Screech691

Screech691 4 minutos hace

Improve Soil Structure
XLR8® Bio is a bio- Organic fertilizer accelerant encapsulating the key technologies for soil enhancement and nutrient management.

BNP Paribas Issuance

Global X Copper Miners U...

BNP Paribas Issuance

BNP Paribas Issuance

BNP Paribas Issuance

BNP Paribas Issuance

BNP Paribas Issuance

Fundo Investimento Imobi...

Clydesdale Resources

Ivbetabuild Ustreas Bd 0...

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones